根据最新的财务报表(Form-10K),KORU Medical Systems Inc 的总资产为 $0,净亏损为 $0
KRMD 的关键财务比率是什么?
KORU Medical Systems Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
KORU Medical Systems Inc 的收入按细分市场或地理位置如何划分?
KORU Medical Systems Inc 最大收入来源是 Domestic Core,在最近的收益报告中收入为 27,992,436。就地区而言, United States 是 KORU Medical Systems Inc 的主要市场,收入为 30,238,333。
KORU Medical Systems Inc 是否盈利?
否,根据最新的财务报表,KORU Medical Systems Inc 的净亏损为 $0
KORU Medical Systems Inc 有负债吗?
否,KORU Medical Systems Inc 的负债为 0
KORU Medical Systems Inc 的流通股有多少?
KORU Medical Systems Inc 的总流通股为 0
关键数据
前收盘价
$3.33
开盘价
$3.37
当日区间
$3.27 - $3.37
52周范围
$3.21 - $6.6
交易量
175.3K
平均成交量
153.5K
股息收益率
--
每股收益(TTM)
-0.04
市值
$152.4M
什么是 KRMD?
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.